Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression

[1]  Xihong Lin,et al.  Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. , 2006, Carcinogenesis.

[2]  R. Millikan,et al.  Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. , 2006, Carcinogenesis.

[3]  W. Guo,et al.  No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. , 2005, Lung cancer.

[4]  P. Laurent-Puig,et al.  Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  Wentan,et al.  Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal Cancer , 2005 .

[6]  W. Tan,et al.  Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal Cancer , 2004, Cancer Research.

[7]  F. Maquart,et al.  Control of melanoma progression by various matrikines from basement membrane macromolecules. , 2004, Critical reviews in oncology/hematology.

[8]  P. Bernard,et al.  The LightTyper: high-throughput genotyping using fluorescent melting curve analysis. , 2003, BioTechniques.

[9]  M. Biondi,et al.  A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  A. Offidani,et al.  Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions , 2002, Cancer.

[11]  V. Kähäri,et al.  High expression levels of collagenase‐1 and stromelysin‐1 correlate with shorter disease‐free survival in human metastatic melanoma , 2002, International journal of cancer.

[12]  L. Matrisian,et al.  Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.

[13]  D. Greaves,et al.  Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene , 2001, The Journal of Biological Chemistry.

[14]  B. Bodey,et al.  Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. , 2001, In vivo.

[15]  D. Ruiter,et al.  Matrix metalloproteinases in human melanoma. , 2000, The Journal of investigative dermatology.

[16]  J. Becker,et al.  Expression and activation of matrix metalloproteinase‐2 (MMP‐2) and its co‐localization with membrane‐type 1 matrix metalloproteinase (MT1‐MMP) correlate with melanoma progression , 2000 .

[17]  J. Becker,et al.  Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. , 2000, The Journal of pathology.

[18]  M. Kallioinen,et al.  MATRIX METALLOPROTEINASE‐2 (72 kD TYPE IV COLLAGENASE) EXPRESSION OCCURS IN THE EARLY STAGE OF HUMAN MELANOCYTIC TUMOUR PROGRESSION AND MAY HAVE PROGNOSTIC VALUE , 1996, The Journal of pathology.

[19]  A. Henney,et al.  Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene Expression* , 1996, The Journal of Biological Chemistry.